Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening

被引:62
作者
Darlin, Lotten [1 ]
Borgfeldt, Christer [1 ]
Forslund, Ola [2 ]
Henic, Emir [1 ]
Hortlund, Maria [2 ,3 ,4 ,5 ]
Dillner, Joakim [3 ,4 ,5 ]
Kannisto, Paivi [1 ,6 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Obstet & Gynaecol, Lund, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Lab Med, Lund, Sweden
[3] Karolinska Hosp & Inst, Dept Lab Med, Stockholm, Sweden
[4] Karolinska Hosp & Inst, Dept Med Epidemiol, Stockholm, Sweden
[5] Karolinska Hosp & Inst, Dept Biostat, Stockholm, Sweden
[6] Kliniken Essen Mitte, Dept Obstet & Gynaecol, D-45136 Essen, Germany
关键词
Screening; Non-attendance; HPV testing; Vaginal smear; Cytology; Self-collected vaginal smear; HIGH-RISK HPV; HUMAN-PAPILLOMAVIRUS DNA; CERVICOVAGINAL LAVAGE; NON-ATTENDANCE; FOLLOW-UP; CANCER; PREVALENCE; ACCURACY; REASONS; SWEDEN;
D O I
10.1016/j.jcv.2013.06.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Many cervical cancers occur among women who have not attended cervical screening. Strategies to reach non-attending women may improve the effectiveness of cervical screening programmes. Objective: To compare the responses among long-term non-attending women to either (i) HPV-testing of a self-collected vaginal sample, or (ii) cytological screening with a flexible no-fee appointment for sampling at an outpatient clinic. Study design: Among the 242,000 women aged 32-65 years in Southern Sweden, we identified 28,635 women who had not had any cervical smears taken for >9 years. We randomized 1000 women to invitation to HPV self-sampling, and 500 women to flexible outpatient clinic appointments. Responding women received a questionnaire about their reasons for previous non-attendance. Results: The response rate to HPV self-sampling was three times higher than the flexible outpatient clinic invitations (147/1000 women (14.7%) compared to 21/500 (4.2%) p < 0.0001). High-risk (hr)-HPV was found in 10/147 self-sampled women (6.9%). 7/10 hr-HPV-positive women attended colposcopy, but no HSIL was found. Among the clinic-sampled women, 2/21 had hr-HPV and 1/21 had HSIL. Reasons for not attending were "uncomfortable with vaginal examination", "feel healthy", "lack of time" and "experience of unfriendly health workers". Conclusions: Although the response rate was low for both interventions, the invitation to vaginal HPV self-sampling was more effective for increasing the coverage of the screening programme. The fact that "uncomfortable with vaginal examination" was the most common reason for non-attending suggests that self-sampling could be further explored as a strategy to increase the coverage of cervical screening programmes. (C) 2013 Elsevier B. V. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 38 条
[1]   Cervical screening in England: The past, present, and future [J].
Albrow, Rebecca ;
Kitchener, Henry ;
Gupta, Nalini ;
Desai, Mina .
CANCER CYTOPATHOLOGY, 2012, 120 (02) :87-96
[2]   Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden [J].
Andrae, Bengt ;
Kemetli, Levent ;
Sparen, Par ;
Silfverdal, Lena ;
Strander, Bjorn ;
Ryd, Walter ;
Dillner, Joakim ;
Tornberg, Sven .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :622-629
[3]   Screening and cervical cancer cure: population based cohort study [J].
Andrae, Bengt ;
Andersson, Therese M-L ;
Lambert, Paul C. ;
Kemetli, Levent ;
Silfverdal, Lena ;
Strander, Bjorn ;
Ryd, Walter ;
Dillner, Joakim ;
Tornberg, Sven ;
Sparen, Par .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[4]   European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document [J].
Arbyn, M. ;
Anttila, A. ;
Jordan, J. ;
Ronco, G. ;
Schenck, U. ;
Segnan, N. ;
Wiener, H. ;
Herbert, A. ;
von Karsa, L. .
ANNALS OF ONCOLOGY, 2010, 21 (03) :448-458
[5]   Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear [J].
Arora, R ;
Kumar, A ;
Prusty, BK ;
Kailash, U ;
Batra, S ;
Das, BC .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 121 (01) :104-109
[6]  
Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3
[7]   Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial [J].
Bulkmans, N. W. J. ;
Berkhof, J. ;
Rozendaal, L. ;
van Kemenade, F. J. ;
Boeke, A. J. P. ;
Bulk, S. ;
Voorhorst, F. J. ;
Verheijen, R. H. M. ;
Groningen, Kvan ;
Boon, M. E. ;
Ruitinga, W. ;
van Ballegooijen, M. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. .
LANCET, 2007, 370 (9601) :1764-1772
[8]   High-risk HPV type-specific clearance rates in cervical screening [J].
Bulkmans, N. W. J. ;
Berkhof, J. ;
Bulk, S. ;
Bleeker, M. C. G. ;
van Kemenade, F. J. ;
Rozendaal, L. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (09) :1419-1424
[9]   Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada [J].
Burchell, AN ;
Richardson, H ;
Mahmud, SM ;
Trottier, H ;
Tellier, PP ;
Hanley, J ;
Coutlée, F ;
Franco, EL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (06) :534-543
[10]   Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity [J].
Darlin, Lotten ;
Borgfeldt, Christer ;
Forslund, Ola ;
Henic, Emir ;
Dillner, Joakim ;
Kannisto, Paivi .
JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (01) :52-56